FDA Investigator Thea C Grome
Thea C Grome has conducted inspections on 83 sites in 7 countries as of 14 Oct 2020. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
83
Last Inspection Date:
14 Oct 2020
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
India,
Netherlands,
Poland,
Malaysia,
Mexico,
Israel
FDA Investigators that have inspected at least one site in common with Thea C Grome:
Adam S Freeman,
Alanna L Mussawwir Bias,
Alexander M Kay,
Alexandria L Capuano,
Alford R Taylor,
Alla Dubrovsky,
Althea A Williams,
Amanda E Lewin, PhD,
Anderson,
Andrea A Branche,
Andrea George, PhD,
Angel K Sandhu,
Angela Shepas,
Anh M Lac,
Anthony E Keller, RPh,
Arindam Dasgupta, PhD,
Ashar P Parikh,
Barbara A Crowl,
Barbara J Wilcox, PhD,
Brian R Hendricks,
Brittany D Mccracken,
Calvin B Koerner,
Carl Lee,
Carole L Jones,
CDR Rochelle B Young, RPh, MSA,
CDR Sean T Creighton,
Celeta S Coves,
Charles A Snipes, PhD,
Christine M Parmentier,
Christopher R Czajka,
Christopher W Buser,
Cindy W Lewis,
Courtney N Long,
Craig A Garmendia,
Cynthia J Tsui,
Daniel J Lahar,
Daniel J Roberts,
Daniel L Aisen,
Darlene B Almogela,
David G Eng,
Deborah A Nebenzahl,
Dolores Harper,
Dr. Mark J Seaton, PhD,
Dr. Ralph M Bernstein, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dustin P Tran,
Dustin R Abaonza,
Dylan D Yao, MD, PhD,
Edward D Harris,
Edward D Vains,
Elizabeth A Dakan,
Emily Shacter,
Eric J Heinze,
Eric L Dong, BS,
Eric W Anderson,
Gene D Arcy,
Geoffrey K Kilili,
Gerald Feldman,
Gerald M Feldman, PhD,
Gerald N Mcgirl, DDS,
Greg K Keshishyan,
Henry K Lau,
Himanshu Gupta, PhD,
Humberto Z Gomez,
Ivar J Sohn,
James A Lane,
James R Evans,
James R Fleckenstein,
Jane M Kreis,
Janet Pulver,
Janete F Guardia,
Jeanne Fringer, PhD,
Jeanne J Thai,
Jeffrey M Watson,
Jeffrey S Buckser,
Jeffrey W Shrifter, DPM,
Jennifer C Adams,
Jennifer L Degroot,
Jennifer L Johnson,
Jessica E Paulsen,
Joan T Briones,
Jocelyn T Ramos,
Joey V Quitania,
Joseph A Seitz, III,
Joseph Kutze, PhD,
Joseph P Iser, MD,
Joshua S Hunt,
Juan A Morales,
Juanita Banuelos,
Jude C Dikes,
Jyoti B Patel, PhD,
Kara A Scheibner, PhD,
Karen J Bak,
Katlin N Stubbs,
Kellia N Hicks,
Kelvin Cheung,
Kendra A Biddick,
Kenya Destin,
Keren Arkin,
Kevin P Foley,
Kristin M Abaonza,
Lakecha N Lewis,
Lakisha M Williams,
Lance A Finnical,
Lance Mde Souza, MBA,
Laree A Tracy,
Laurie P Norwood,
Lavender M Huskey,
Laverne Puckett,
LCDR Jennifer H Rhyu,
Leonard H Lavi,
Linda Linh N Adams,
Linh Tu,
Lori A Gioia,
Lori J Silverstein,
Lucila B Nwatu,
Lydia S Chan,
Mabel M Lee,
Maida Henesian (NMI),
Marie K Kinkade,
Mariza M Jafary,
Mark E Chan,
Mark W Babbitt,
Marsha W Major,
Mary R Hole,
Mathew T Thomas, MD,
Matthew M Vernon,
Melissa A Torres,
Melkamu Getie Kebtie, PhD,
Mendoza O Wallace,
Michael Shanks, MS,
Michael T Cyrus,
Michelle Rfrazier Jessen, PhD,
Mihaly S Ligmond,
Min Shanmabel Liu,
Mohsen Rajabi Abhari, FDA,
Nayan J Patel,
Nicholas L Hunt,
Nicholas Obiri, PhD,
Nicola M Fenty Stewart,
Nicole M Bell,
Nicole M Gillette,
Omotunde O Osunsanmi,
Paul M Kawamoto,
Paula J Bretz,
Peter E Baker,
Peter Kessler, PhD,
Quynh H Strandberg,
Quynh Van Tran,
Raymond T Oji,
Rebecca Rodriguez,
Rebecca T Davis,
Riley C Myers, PhD,
Robert D Tollefsen,
Ruben C Ayala, PharmD,
Sandra S Saniga,
Scott B Laufenberg,
Scott N Lim,
Serge L Beaucage,
Sergio Chavez (NMI),
Sheilyn H Huang,
Shelley H Beausoleil,
Sherri J Jackson,
Sherri N Rohlf, MD,
Sidney B Priesmeyer,
Sripal R Mada, PhD,
Stephanie A Slater, MS,
Stuart W Russell,
Sunitha K Rajaram, PhD,
Susan D Yuscius,
Susanne M Richardson, MS RAC,
Suzanne M Healy,
Tania Y Hall,
Tawny L Colling,
Teena H Aiken,
Thomas W Nojek,
Thuy T Nguyen, LCDR,
Timothy C Grome,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Walden H Lee,
William J Foust,
William V Millar,
Xiaohan Cai, PhD,
Yi Wang, PhD,
Young M Choi, PhD
Thea C Grome's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more